The future of CBD: Is the hemp market hurtling towards a crash?

Cannabidiol (CBD) may be entering mainstream, but Rabobank analysts argue that legal ambiguities and underregulation are the key deterrents for entrants to this new market

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

19 Jun 2019 --- Set to be launched in September, the International Cannabinoid Analysis Program (ICAP) is a new third-party certification program for manufacturers and brands in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Jun 2019 --- US-based hemp ingredients company Victory Hemp Foods has launched two new functional and proprietary ingredients – Victory ONE Hemp Heart Oil and V-70 Hemp... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Jun 2019 --- Cannabinoid (CBD) manufacturer Noramco and Willow Biosciences, a developer of biosynthetic production systems for plant-derived active pharmaceutical ingredients... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

31 May 2019 --- A synthetic, non-intoxicating cannabidiol (CBD) alternative, 8,9-Dihydrocannabidiol (H2CBD) was found to be as effective in treating the frequency and severity of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 May 2019 --- Regulatory confusion over cannabinoids (CBD) has opened up the space for alternatives, within which Gencor has released Levagen, a palmitoylethanolamide (PEA)... Read More